DNA/RNA/Nucleic AcidsMarch 19, 20267 min read

Everything You Need to Know About DNA repair mechanisms for Step 1

Deep dive: definition, pathophysiology, clinical presentation, diagnosis, treatment, HY associations for DNA repair mechanisms. Include First Aid cross-references.

Everything You Need to Know About DNA Repair Mechanisms for Step 1

DNA is constantly being damaged—by UV light, ionizing radiation, reactive oxygen species, and replication errors. The USMLE loves DNA repair because the mechanisms are high-yield, testable by clues, and tightly linked to classic diseases (e.g., xeroderma pigmentosum, Lynch syndrome, ataxia-telangiectasia, Fanconi anemia).


Big-Picture Definition (What is DNA Repair?)

DNA repair mechanisms are cellular pathways that detect and correct DNA damage to maintain genomic stability. Failure of repair → mutations, cancer predisposition, cell death, and developmental defects.

Step 1 framing:

  • Identify the type of damage (UV dimers? mismatch? double-strand break?)
  • Map it to the repair pathway
  • Connect to associated disease, cancer risk, and clinical clues

First Aid cross-reference: Biochemistry → Nucleic acid structure and function / DNA repair (often also echoed in Pathology → Neoplasia for mismatch repair and cancer syndromes).


High-Yield Classification: Match Damage → Repair Pathway

1) Nucleotide Excision Repair (NER) — “Cut out bulky lesions”

Fixes: bulky, helix-distorting lesions (classically UV-induced pyrimidine dimers)
Mechanism (Step-style):

  • Recognize distortion
  • Endonuclease cuts on both sides
  • Remove damaged segment
  • DNA polymerase fills
  • DNA ligase seals

Classic association: Xeroderma pigmentosum (XP)

  • Defect: NER
  • Clinical presentation:
    • Severe sunburns and photosensitivity
    • Freckling at early age
    • Markedly increased risk of skin cancers (SCC, BCC, melanoma)
  • Diagnosis clues:
    • History of extreme sun sensitivity + early skin malignancies
  • Treatment/management (testable concepts):
    • Strict UV avoidance, protective clothing
    • Aggressive dermatologic surveillance and early excision of lesions

USMLE pearl: UV damage → think pyrimidine dimers → think NER → think XP.


2) Base Excision Repair (BER) — “Fix small, non–helix-distorting damage”

Fixes: small base changes that don’t massively distort the helix
Examples:

  • Deamination (e.g., cytosine → uracil)
  • Oxidation (ROS damage; 8-oxoG)
  • Alkylation

Mechanism:

  • DNA glycosylase removes the abnormal base → creates AP (abasic) site
  • AP endonuclease cuts backbone
  • DNA polymerase fills
  • Ligase seals

Clinical relevance: not usually tested as a single named syndrome in Step 1 the way NER/MMR are, but frequently tested conceptually:

  • ROS damage increases with radiation/oxidative stress
  • BER is a “housekeeping” pathway for daily spontaneous lesions

3) Mismatch Repair (MMR) — “Fix replication errors”

Fixes: replication errors that escape proofreading:

  • Base-base mismatches
  • Insertion/deletion loops (especially in microsatellites)

Core concept: identifies the newly synthesized strand and repairs to match the template.

Classic association: Lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer, HNPCC)

  • Defect: MMR genes (classically MLH1, MSH2, also MSH6, PMS2)
  • Pathophysiology:
    • Failure to repair replication errors → microsatellite instability
    • Increased mutations in growth-regulatory genes
  • Clinical presentation (HY):
    • Colon cancer often proximal/right-sided
    • Also endometrial, ovarian, gastric cancers (and others)
    • Fewer polyps than FAP, but high malignant potential
  • Diagnosis (Step-relevant):
    • Tumor testing: microsatellite instability or loss of MMR proteins on IHC
    • Family history patterns (early onset, multiple related cancers)
  • Treatment/management:
    • Increased surveillance (colonoscopy earlier/more frequently)
    • Cancer treatment per staging; some tumors respond to immunotherapy in real practice (checkpoint inhibitors), but for Step 1 focus on mechanism + associations

USMLE pearl: Microsatellite instability = MMR failure = Lynch.

First Aid cross-reference: DNA repair + colorectal cancer genetics (also appears in GI pathology sections).


4) Double-Strand Break (DSB) Repair

Double-strand breaks are among the most lethal forms of DNA damage.

A) Nonhomologous End Joining (NHEJ) — “Quick and dirty”

When: throughout cell cycle (especially G1)
How: directly ligates broken ends
Risk: error-prone → small insertions/deletions

Clinical tie-in (conceptual):

  • Important in immune system gene rearrangement (V(D)J), but Step questions often emphasize that defects increase genomic instability.

B) Homologous Recombination (HR) — “Accurate template-based repair”

When: S/G2, when a sister chromatid is available
How: uses the intact sister chromatid as a template
More accurate than NHEJ

High-yield cancer association: BRCA1/BRCA2 involved in HR repair

  • Increased risk: breast and ovarian cancers (also prostate, pancreatic)

First Aid cross-reference: Tumor suppressors (BRCA) and DNA repair.


ATM, Cell Cycle Checkpoints, and Radiation: A Classic Step 1 Cluster

Ataxia-telangiectasia (ATM mutation)

ATM helps sense DNA damage (especially double-strand breaks) and coordinates cell cycle checkpoint arrest (notably at G1/S) and repair.

Clinical presentation (HY):

  • Progressive cerebellar ataxia
  • Telangiectasias
  • Recurrent sinopulmonary infections (often due to IgA deficiency and broader immune dysfunction)
  • Increased risk of malignancies (especially leukemia/lymphoma)
  • Radiation sensitivity

Diagnosis clues:

  • Child with ataxia + telangiectasias + recurrent infections
  • Lab patterns may show immunoglobulin abnormalities; Step often tests the triad and radiation sensitivity

USMLE pearl: Radiation sensitivity and cancer predisposition point to DNA repair/checkpoint disorders.


Fanconi anemia

Defect: DNA repair of interstrand crosslinks (classically from agents like chemotherapy; crosslinks block replication/transcription)
Pathophysiology: bone marrow failure + cancer risk from chromosomal instability.

Clinical presentation (HY mnemonic-style features):

  • Pancytopenia / aplastic anemia (bone marrow failure)
  • Increased AML risk
  • Congenital anomalies: abnormal thumbs/radii, short stature, café-au-lait spots (congenital malformation pattern is commonly tested)

Diagnosis (Step-style):

  • Chromosomal breakage tests may be referenced
  • Clinical picture: child with physical anomalies + pancytopenia

Treatment/management:

  • Supportive care (transfusions, infection management)
  • Hematopoietic stem cell transplant is definitive for marrow failure

First Aid cross-reference: Often appears under hematology (aplastic anemia) as well as biochemistry DNA repair.


Putting It Together: Common Step 1 Presentations (Clinical Vignettes)

Vignette 1

Child with extreme sun sensitivity, early skin cancers.
Answer: Xeroderma pigmentosumnucleotide excision repair defect (UV pyrimidine dimers).

Vignette 2

Right-sided colon cancer + endometrial cancer in family; tumor has microsatellite instability.
Answer: Lynch syndromemismatch repair defect.

Vignette 3

Child with ataxia, telangiectasias, recurrent infections; radiation sensitivity.
Answer: ATM mutation (checkpoint/DSB response).

Vignette 4

Child with pancytopenia + thumb abnormalities.
Answer: Fanconi anemia → crosslink repair defect → marrow failure, AML risk.


Diagnosis: What Tests/Clues Matter for Step 1?

You usually won’t be asked to order an exhaustive workup, but you will be tested on hallmark findings:

  • XP: early skin cancers + UV sensitivity (mechanism: NER)
  • Lynch: microsatellite instability / loss of MMR proteins; proximal colon cancer
  • ATM: ataxia + telangiectasia + recurrent infections + radiation sensitivity
  • Fanconi: aplastic anemia + congenital anomalies; increased AML risk
  • BRCA: familial breast/ovarian cancer pattern; HR defect

Treatment/Management: Step-Relevant Principles

While Step 1 is mechanism-heavy, keep these high-yield management anchors in mind:

  • UV-related repair defects (XP): strict sun avoidance, frequent dermatologic checks
  • Lynch: earlier and more frequent cancer screening (colon/endometrial awareness)
  • Fanconi: supportive care; stem cell transplant for marrow failure
  • ATM: supportive management; reduce radiation exposure (radiation sensitivity)
  • BRCA-associated cancers: screening and risk reduction strategies may be mentioned; core testable concept is DNA repair (HR) defect

Rapid High-Yield Table (Memorize This)

Damage TypeRepair MechanismKey Enzyme/ConceptClassic Association
UV pyrimidine dimers (bulky lesion)Nucleotide excision repairendonuclease excision + re-synthesisXeroderma pigmentosum
Small base damage (oxidation, deamination)Base excision repairDNA glycosylase → AP siteConceptual (ROS/aging/radiation)
Replication mismatches, microsatellitesMismatch repairfixes post-replication errorsLynch syndrome
Double-strand breaksNHEJ / HRNHEJ error-prone; HR uses sister chromatidBRCA1/2 (HR), genomic instability
DNA damage sensing/checkpointsATM pathwaycheckpoint arrest + repair coordinationAtaxia-telangiectasia
Interstrand crosslinksCrosslink repair pathwayschromosomal instabilityFanconi anemia

First Aid Cross-References (Where This Shows Up Again)

Even if the primary entry is in Biochemistry, DNA repair repeats across FA in multiple contexts:

  • Biochemistry: DNA repair mechanisms (NER/BER/MMR, etc.)
  • Pathology (Neoplasia): tumor suppressors and genomic instability (e.g., BRCA, MMR/Lynch)
  • Dermatology/Oncology: UV-associated skin cancers (XP concept)
  • Hematology: aplastic anemia and marrow failure (Fanconi anemia)
  • Immunology: recurrent infections in ATM (immune dysfunction)

Ultra–High-Yield Facts to Nail Before Test Day

  • UV pyrimidine dimers → NER → xeroderma pigmentosum
  • Microsatellite instability → mismatch repair defect → Lynch syndrome
  • ATM mutation → ataxia-telangiectasia → radiation sensitivity + infections + cancer
  • Fanconi anemia → crosslink repair defect → aplastic anemia + AML risk + thumb anomalies
  • BRCA1/2 → homologous recombination defect → breast/ovarian cancer predisposition